Results 61 to 70 of about 16,507 (152)

Therapeutic interventions for chronic central serous chorioretinopathy: a comprehensive assessment of systematic reviews

International Journal of Retina and Vitreous
Background A variety of different treatments have been proposed to effectively treat chronic central serous chorioretinopathy but there remains uncertainty regarding the efficacy of a number of treatment options.
Henok Getahun, Rajendra S. Apte
doaj   +1 more source

Aldosterone receptor antagonists: current perspectives and therapies

Vascular Health and Risk Management, 2013
Jason L Guichard, Donald Clark III, David A Calhoun, Mustafa I Ahmed University of Alabama at Birmingham, Department of Medicine, Division of Cardiovascular Disease, Vascular Biology and Hypertension Program, Birmingham, AL, USA Abstract: Aldosterone is ...
Guichard JL, Clark III D, Calhoun DA, Ahmed MI   +3 more
doaj  

Mineralocorticoid receptor antagonists for primary aldosteronism—appropriate or not?

European Journal of Endocrinology, 2023
Oskar Ragnarsson, Per Dahlqvist, Andreas Muth, Jan Calissendorff, Tommy Olsson   +4 more
openaire   +3 more sources

Mineralocorticoid receptor antagonists in the treatment of patients with chronic heart failure. Positions in 2015

Терапевтический архив, 2015
Mineralocorticoid receptor antagonists (MCRA) are part of standard medical therapy for heart failure (HF). The clinical efficacy of MCRA in patients with systolic HF has been proven by randomized clinical trials.
Yu F Osmolovskaya, I V Zhirov, S N Tereshchenko   +2 more
doaj  

Mineralocorticoid receptor antagonists and mortality in hypertension: a systematic review and meta-analysis. [PDF]

J Hypertens
Teh JW, Comerford G, Surlis G, Curneen J, Krewer F, Smyth A, Lappin D, Mcevoy JW, Dennedy MC, Judge C.   +9 more
europepmc   +1 more source

Mineralocorticoid receptor antagonists for the treatment of heart failure and kidney disease: a state-of-the-art review. [PDF]

Heart Fail Rev
Van Spall HGC, Vardeny O.
europepmc   +1 more source

Mineralocorticoid receptor antagonists: Efficacy and safety in chronic kidney disease. [PDF]

Diabetes Obes Metab
Mottl AK, Khunti K, Mathieu C.
europepmc   +1 more source

Nonsteroidal Mineralocorticoid Receptor Antagonists in Heart Failure: Mechanistic Basis, Clinical Evidence, and Therapeutic Integration. [PDF]

Drugs Drug Candidates
Al-Horani RA, Goyal N.
europepmc   +1 more source

Mineralocorticoid Receptor Antagonists in Chronic Kidney Disease: Clinical Evidence, Pharmacology, and Drug-Drug Interactions for Personalized Management of Hyperkalemia. [PDF]

Int J Mol Sci
Hirai T, Katayama K.
europepmc   +1 more source

Mineralocorticoid receptor antagonists in heart failure with sustained monomorphic ventricular tachycardia: comparative analysis of spironolactone versus eplerenone. [PDF]

Open Heart
Szakál I, Komlósi F, Tóth P, Arnóth B, Bohus G, Vámosi P, Szegedi N, Salló Z, Osztheimer I, Perge P, Orbán G, Kardos A, Merkely B, Gellér L, Nagy KV.   +14 more
europepmc   +1 more source